International Journal of Hematology

, Volume 73, Issue 2, pp 222–225 | Cite as

Low Frequency ofBCL10 Gene Mutations in B-Cell Non-Hodgkin’s Lymphoma

  • Jiro Tadokoro
  • Yuichi Nakamura
  • Shinpei Furusawa
  • Kinuko Mitani
Case Report


TheBCL10 gene was identified at the breakpoint region of the t(1;14)(p22;q32) translocation in mucosa-associated lymphoid tissue lymphoma. Initially, mutations in theBCL10 gene were reported to occur at a high frequency in various types of lymphomas and solid tumors. However, subsequent studies showed that the mutations were rarely recognized.To evaluate the frequency and spectrum of its mutations in B-cell non-Hodgkin’s lymphoma (B-NHL), we screened 56 cases with B-NHL by mutation analysis of exons 2 and 3 of the gene. In addition to 2 polymorphisms, a frame-shift mutation and a missense mutation were identified in 2 cases (3.6%): 1 with diffuse large B-cell lymphoma and the other with mantle cell lymphoma. Both cases showed mutations within exon 3, resulting in a C-terminal truncation in the former and a C-terminal amino acid substitution in the latter. Reverse transcriptase-polymerase chain reaction analysis of the former case revealed that both the mutated and the wild-type alleles were transcribed with or without a sequence modification. Our results, together with recent reports, indicate thatBCL10 gene mutations take place in a small population of B-NHL and are not associated with specific histological subtypes.

Key words

BCL10 gene Non-Hodgkin’s Lymphoma Mutations 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Willis TG, Jadayel DM, Du MQ, et al.BCL10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.Cell. 1999;96:35–45.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and over-expression o.BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).Nat Genet. 1999;22:63–68.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Koseki T, Inohara N, Chen S, et al. CIPER, a novel NF κB-activating protein containing a caspase recruitment domain with homology t. herpesvirus-2 protein E10.J Biol Chem. 1999;274:9955–9961.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Thome M, Maritinon F, Hofmann K, et al. Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-κB transcription factor and c-Jun N-terminal kinase.J Biol Chem. 1999;274:9962–9968.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Yan M, Lee J, Schilbach S, Goddard A, Dixit V. mE10, a novel caspase recruitment domain-containing proapoptotic molecule.J Biol Chem. 1999;274:10287–10292.CrossRefPubMedGoogle Scholar
  6. 6.
    Fakruddin JM, Chaganti RSK, Murty VVVS. Lack o.BCL10 mutations in germ cell tumors and B cell lymphomas.Cell. 1999;97:683–684.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Apostolou S, Rienzo AD, Murthy SS, Jhanwar SC, Testa JR. Absence o.BCL10 mutations in human malignant mesothelioma.Cell. 1999;97:684–686.CrossRefPubMedGoogle Scholar
  8. 8.
    Gill S, Broni J, Jefferies S, et al.BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas.Br J Cancer. 1999;80:1565–1568.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Stone JG, Rowan AJ, Tomlison IPM, Houlston RS. Mutations i.BCL10 are very rare in colorectal cancer.Br J Cancer. 1999;80:1569–1570.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    van Schothorst EM, Mohkamsing S, van Gurp RJHLM, Oosterhuis JW, van der Saag PT, Looijenga LHJ. Lack o.BCL10 mutations in testicular germ cell tumours and derived cell lines.Br J Cancer. 1999;80:1571–1574.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lambers AR, Gumbs C, Ali S, et al.BCL10 is not a target for frequent mutation in human carcinomas.Br J Cancer. 1999;80:1575–1576.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Takahashi H, Hosokawa Y, Suzuki R, Morishima Y, Nakamura S, Seto M. Infrequen.BCL10 mutations in B-cell non-Hodgkin’s lymphomas.Jpn J Cancer Res. 1999;90:1316–1320.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Luminari S, Intini D, Baldini L, et al.BCL10 gene mutations rarely occur in lymphoid malignancies.Leukemia. 2000;14:905–908.CrossRefPubMedGoogle Scholar
  14. 14.
    Du MQ, Peng H, Liu H, et al.BCL10 gene mutation in lymphoma.Blood. 2000;95:3885–3890.PubMedGoogle Scholar
  15. 15.
    Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.Blood. 1994;84:1361–1392.PubMedGoogle Scholar
  16. 16.
    Grimwade D, Du MQ, Langabeer S, et al. Screening for mutations o.BCL10 in leukemia.Br J Cancer. 2000;109:611–615.Google Scholar
  17. 17.
    Takahashi H, Maeda Y, Seto M, Hosokawa Y. Nucleotide insertions and deletions within the homopolymeric runs of adenines and thymidines o.BCL10 cDNA in normal peripheral blood leukocytes.Blood. 2000;15:2728–2729.Google Scholar
  18. 18.
    Dyer MJS, Price HP, Jadayel DM, et al. In response to Fakruddin et al and Apostolou et al.Cell. 1999;97:686–688.CrossRefGoogle Scholar
  19. 19.
    Dyer MJ.BCL10 mutations in malignancy.Br J Cancer. 1999;80:1491.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Jiro Tadokoro
    • 1
  • Yuichi Nakamura
    • 1
  • Shinpei Furusawa
    • 1
  • Kinuko Mitani
    • 1
  1. 1.Department of HematologyDokkyo University School of MedicineTochigiJapan

Personalised recommendations